The CMS may have paid providers more than $729 million in incentive payments for EHR systems that didn't comply with federal standards, according to HHS' Office of Inspector General.
The Food and Drug Administration took steps Tuesday to try to curb drug prices by increasing competition in the pharmaceutical market. The agency published a list of off-patent branded drugs without approved generics and will expedite review of generic drugs that have few competitors.
Medtronic and Aetna announced a new risk-based agreement for Type 1 and Type 2 diabetes patients who transition to Medtronic's insulin injectors. The deal aims to increase accountability and lower costs by tying reimbursement to outcomes.
When it comes to getting emergency health services to cardiac patients, the fastest route may be as the drone flies. Recent studies in Canada and Sweden have shown some promising data with simulations of delivering care from the sky.